VTT Technical Research Centre of Finland Ltd., P.O Box 1000, FI-02044 VTT, Finland.
Food Funct. 2020 Jul 1;11(7):6680-6691. doi: 10.1039/d0fo00367k. Epub 2020 Jul 13.
The objective of this work was to evaluate the role of β-glucan molecular weight (M) and the presence of other carbohydrates on the physiological functionality of oat bran via an in vitro digestion study. A complete approach using three different in vitro digestion models (viscosity of the small intestine digest, reduction of bile acids and on-line measurement of gas evolution) was used to predict the physiological functionality of enzymatically modified oat bran concentrate (OBC). OBC was enzymatically treated with two β-glucanase preparations at three different levels in order to specifically decrease β-glucan M (Pure: purified β-glucanase) or β-glucan and other cell wall polysaccharides (Mix: commercial food-grade cell wall degrading enzyme preparation). The M of β-glucan in OBC was tailored to high (1000 kDa), medium (200-500 kDa) and low (<100 kDa) values. The amount of arabinoxylan-oligosaccharides varied from 0.3 to 4.7 g per 100 g of OBC when OBC was treated with the Mix enzyme at the highest dosage. When the enzymatically treated OBCs were studied in an upper gut model, a decrease in the viscosity of the digest simultaneously with the reduction of β-glucan M was observed. At a similar β-glucan M range, OBC samples treated with the Pure enzyme had lower viscosity than the samples treated with the Mix one, which also contained arabinoxylan-oligosaccharides. After enzymatic hydrolysis, the capacity of OBC to reduce bile acid was decreased regardless of the enzyme treatment used, and a positive correlation was found between β-glucan M and bile acid reduction (r = 0.99**). The production of colonic gases by the enzymatically treated OBC samples in an in vitro colon model showed an inverse correlation between β-glucan M and initial rate of gas formation (r = -0.9**), but no impact of arabinoxylan-oligosaccharides was observed. This study emphasised the complexity of factors affecting the functionality of oat components under physiological conditions and demonstrated the possibility to produce M-tailored oat fibre ingredients that could contribute to gut mediated health benefits.
本研究旨在通过体外消化研究评估β-葡聚糖分子量(M)和其他碳水化合物的存在对燕麦麸皮生理功能的影响。采用三种不同的体外消化模型(小肠消化粘度、胆汁酸还原和在线气体生成测量)的综合方法,预测经酶法改性的燕麦麸浓缩物(OBC)的生理功能。OBC 经两种β-葡聚糖酶制剂在三种不同水平下进行酶处理,以特异性降低β-葡聚糖 M(Pure:纯化的β-葡聚糖酶)或β-葡聚糖和其他细胞壁多糖(Mix:商业食品级细胞壁降解酶制剂)。OBC 中的β-葡聚糖 M 被定制为高(1000 kDa)、中(200-500 kDa)和低(<100 kDa)值。当 OBC 用 Mix 酶处理最高剂量时,OBC 中的阿拉伯木聚糖低聚糖含量为 0.3-4.7 g/100 g。当在肠道上模型中研究经酶处理的 OBC 时,同时观察到消化物粘度降低和β-葡聚糖 M 降低。在相似的β-葡聚糖 M 范围内,用 Pure 酶处理的 OBC 样品的粘度低于用 Mix 酶处理的样品,后者还含有阿拉伯木聚糖低聚糖。酶水解后,无论使用哪种酶处理,OBC 降低胆汁酸的能力都会降低,并且β-葡聚糖 M 与胆汁酸还原之间存在正相关关系(r = 0.99**)。在体外结肠模型中,经酶处理的 OBC 样品产生结肠气体的速率与β-葡聚糖 M 呈负相关(r = -0.9**),但未观察到阿拉伯木聚糖低聚糖的影响。本研究强调了在生理条件下影响燕麦成分功能的因素的复杂性,并证明了生产可定制 M 的燕麦纤维成分的可能性,这些成分可能有助于肠道介导的健康益处。